Kathleen Walker

Kathleen Walker is an accomplished professional with extensive experience in regulatory affairs and pharmaceutical development. Currently serving as Executive Director Regulatory CMC at Xencor since 2020, Kathleen previously held the position of Senior Director at NDA Group AB and served as Senior Director of Chemistry, Manufacturing and Controls at La Jolla Pharmaceutical Company. Kathleen's past roles include Site Head of Regulatory Affairs at Gilead Sciences, Director of Scientific Consulting at Cardinal Health Specialty Solutions, and various leadership positions at Eisai Pharmaceuticals, Ligand Pharmaceuticals, and Isis Pharmaceuticals. Kathleen holds a PhD in Physical Chemistry from the University of California, San Diego, and has completed postdoctoral fellowships in bioanalytical and high-resolution mass spectroscopy at The Johns Hopkins University and the University of California, Riverside.